Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 464 | 303 | 258 | 244 | -15 |
| Gross Profit | 464 | 303 | 258 | 244 | -15 |
| Operating Expenses | 17,187 | 19,849 | 20,311 | 16,048 | 14,480 |
| Operating Income | -16,723 | -19,546 | -20,053 | -15,804 | -14,495 |
| Other Income | 456 | 647 | 636 | 709 | 860 |
| Pre-tax Income | -16,267 | -18,899 | -19,417 | -15,095 | -13,635 |
| Income Tax | N/A | N/A | N/A | N/A | -14 |
| Net Income Continuous | -16,260 | -18,899 | -19,417 | -15,095 | -13,621 |
| Net Income | $-16,274 | $-18,899 | $-19,417 | $-15,095 | $-13,635 |
| EPS Basic Total Ops | -0.37 | -0.45 | -0.54 | -0.47 | -0.44 |
| EPS Basic Continuous Ops | -0.37 | -0.45 | -0.54 | -0.47 | -0.43 |
| EPS Diluted Total Ops | -0.37 | -0.45 | -0.54 | -0.47 | -0.44 |
| EPS Diluted Continuous Ops | -0.37 | -0.45 | -0.54 | -0.47 | -0.43 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.45 | -0.54 | -0.47 | -0.43 |
| EBITDA(a) | $-16,802 | $-19,634 | $-20,145 | $-15,889 | $-14,583 |